Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Iterum Therapeutics Reports Second Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Iterum Therapeutics plc

PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting with the FDA and Alignment on a Single, Non-Randomized Phase 3 Trial to Support BLA Submission for PB2452

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  PhaseBio Pharmaceuticals Inc.

Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Prevail Therapeutics Inc.

Ogilvy Health Further Cultivates Creative Community With Multiple Promotions

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019

Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Onconova Therapeutics, Inc.

Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019

Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Scholar Rock, Inc.

Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Avenue Therapeutics, Inc.

resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  resTORbio, Inc.

Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019

BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Brainsway Ltd.

aTyr Pharma Announces Second Quarter 2019 Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Atyr Pharma, Inc. | Pharmsynthez

Progyny Ranks #59 on the 2019 Inc. 5000

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Progyny, Inc.

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Acasti Pharma, Inc.

Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Akari Therapeutics Plc

Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Gritstone Oncology, Inc.

Replimune Reports First Fiscal Quarter Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Replimune Group, Inc.

Novan Advances Women’s Health Business Unit with Non-Dilutive Funding

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Novan, Inc.

Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  Vaccinex, Inc

RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2019
Related companies:  RenovaCare, Inc.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑